For people with inflammatory bowel disease, following a Ramadan intermittent fasting schedule for one month does not lead to measurable changes in their quality of life or levels of depression, based on standard clinical assessments.

Among people with inflammatory bowel disease, fasting during Ramadan for one month does not lead to hospital visits or changes in prescribed medications, even if some individuals experience increased symptoms.

During Ramadan fasting, people with ulcerative colitis may experience worsening symptoms, while those with Crohn’s disease typically do not show a change in symptoms, suggesting that fasting affects these two conditions differently.

In patients with ulcerative colitis, fasting during Ramadan for 14 to 15 hours per day is linked to a small but measurable increase in disease activity symptoms, especially in individuals aged 30 or older or those with higher baseline levels of fecal calprotectin, without corresponding changes in blood or stool markers of inflammation.

In people with Crohn’s disease, fasting during Ramadan does not lead to measurable changes in blood markers of inflammation or symptom severity over one month.

Adults aged 30 and older with ulcerative colitis may have more severe symptoms during Ramadan fasting than younger adults with the same condition, even when accounting for differences in medication or how long they've had the disease.